Mydecine Innovations Group Inc. (AQU: MYIG)

Market Cap	285.17K
Revenue (ttm)	n/a
Net Income (ttm)	-6.88M
Shares Out	n/a
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	1.750
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 31, 2025

About AQU: MYIG

Mydecine Innovations Group Inc., a biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. Its lead product drug candidates include MYCO-005. The company also develops MYCO-006 and MYCO-007. Mydecine Innovations Group Inc. has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entacto...

• Industry: Agricultural Production Crops
• Founded: 2013
• Country: Canada
• Stock Exchange: Aquis Exchange
• Ticker Symbol: MYIG

Financial Performance

Financial numbers in CAD